Lerner Medical Introduces Levia® To Dermatology Professionals

Los Angeles, CA--(Marketwire) - Lerner Medical Devices, Inc. (LMD) announces its continued support of professional dermatology meetings to introduce Levia®, a new class of ultraviolet (UVB) medical device. Levia provides Personal Targeted Phototherapy®, a safe and effective non-drug option for the self-treatment of scalp and small area psoriasis in the privacy and convenience of a patient's home. In response to many inquiries, LMD is implementing a comprehensive program to inform dermatologists and dermatology nurses who are requesting additional information about Levia.

"We have received considerable interest in Levia, and we are pleased to be introducing it to hundreds of additional dermatology professionals over the next few months," said John R. Lyon, Chief Executive Officer of LMD. "We are convinced that Levia will improve treatment effectiveness and convenience for psoriasis patients."

Levia was demonstrated at both American Academy of Dermatology conventions this year, most recently at the Summer Meeting in Chicago, IL, August 4th-8th. Participation in other dermatology meetings included introduction of Levia at the Pacific Dermatologic Association's 62nd Annual Meeting in Pasadena, CA, August 11th-14th and the Controversies and Conversations in Laser and Cosmetic Surgery Symposium in Carlsbad, CA, August 13th-15th.

Also, from September 24th-26th, Levia will be demonstrated to more than 200 dermatologists during the CalDerm Annual meeting in Santa Barbara, CA. The final 2010 meeting for Levia will be the Dermatology Nursing Institute (DNI) Annual Congress, October 6th-8th, in Las Vegas, NV.

All of the meetings are designed to educate attendees and introduce professionals to current and evolving research, as well as the newest advancements in technology to improve practice management skills and refine techniques.

For more information on Levia, Lerner Medical Devices, or any of the referenced professional meetings visit www.mylevia.com.

About Lerner Medical Devices, Inc.
Lerner Medical Devices (www.lernermedical.com) is focused on the use of ultraviolet B (UVB) phototherapy for self-treatment of psoriasis and other photo-responsive skin conditions. Levia® is the first of their Personal Targeted Phototherapy® products.

Levia® provides Personal Targeted Phototherapy® for the self-treatment of psoriasis in the privacy and convenience of a patient's home. Levia incorporates easy to use software for physician control of dosimetry and includes two proprietary beam delivery attachments, the LiteBrush and LiteSpot, which ensure precise and safe delivery of therapeutic UVB light.

To learn more about Levia® and Lerner Medical, please visit www.mylevia.com.

SOURCE: Lerner Medical Devices, Inc.